GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Titan Medical Inc (OTCPK:TMDIF) » Definitions » COGS-to-Revenue

Titan Medical (Titan Medical) COGS-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Titan Medical COGS-to-Revenue?

Titan Medical's Cost of Goods Sold for the three months ended in Dec. 2023 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was $0.50 Mil.

Titan Medical's COGS to Revenue for the three months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Titan Medical's Gross Margin % for the three months ended in Dec. 2023 was N/A%.


Titan Medical COGS-to-Revenue Historical Data

The historical data trend for Titan Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Medical COGS-to-Revenue Chart

Titan Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Titan Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Titan Medical COGS-to-Revenue Calculation

Titan Medical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 17.632
=0.00

Titan Medical's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0.5
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Titan Medical  (OTCPK:TMDIF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Titan Medical's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0.5
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Titan Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Titan Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Medical (Titan Medical) Business Description

Traded in Other Exchanges
Address
76 Berkeley Street, Toronto, ON, CAN, M5A 2W7
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.